Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559819 · ClinicalTrials.gov registry record · Phase 3
Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
A Phase 3 study of Impairment and Driving, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT00559819 is a Phase 3 study of Impairment and Driving that has completed, run by Rush University Medical Center. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00559819, a Phase 3 study of Impairment and Driving, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will validate and determine sensitivity of our new driving simulator, created to evaluate driving ability in a related study to show similar driving performance between patients on chronic opioid treatment and a control group. Although the commercial version of the simulator has been validated for certain populations and certain measures, these require re-calibration for our own clinical study. The investigators propose a prospective randomized clinical trial to evaluate driving skills under alcohol consumption using a driving simulator. Two groups of study subjects will be utilized, with the majority (80%) receiving alcohol and placebo at different times. A smaller set of study subjects (20%) will be given placebo on both trials to evaluate learning effects and placebo blinding effectiveness. Each group will take the driving test at three time points: once as a baseline at the beginning of the study, once after the 1st dosing of the placebo and again after dosing two of the alcohol or placebo beverage. This information will allow us to evaluate driving ability under other potentially impairing conditions such as opioid usage.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Alcohol
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-02 |
| Est. Completion | 2022-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00559819
The ClinicalTrials.gov registry entry for NCT00559819 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Impairment appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00559819 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00559819 about?
NCT00559819 is a clinical study titled "Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving". The proposed study will validate and determine sensitivity of our new driving simulator, created to evaluate driving ability in a related study to show similar driving performance between patients on chronic opioid treatment and a control group. Although the commercial version of the simulator has b...
What is the current status of trial NCT00559819?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2008-02. Estimated completion is 2022-07.
What conditions does trial NCT00559819 study?
This clinical trial studies the following conditions: Impairment, Driving, Intoxication, Alcohol Impaired Driving.
What interventions are being tested in trial NCT00559819?
The interventions under investigation include: placebo (DRUG), Alcohol (DRUG).
Who is sponsoring clinical trial NCT00559819?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00559819 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.